{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-028099","form_type":"8-K","ticker":"LFST","cik":"0001845257","company_name":"LifeStance Health Group, Inc.","filed_at":"2025-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.252289+00:00","generated_at":"2026-05-26T02:29:18.451468+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"LifeStance Q4 revenue $325.5M (+16% YoY); 2025 EBITDA guidance $130-150M","bullets":["Q4 revenue $325.5M (+16% YoY); full year $1.251B (+19% YoY).","Net loss narrowed to $7.1M in Q4 vs $45.0M prior; full year $57.4M vs $186.3M.","Adjusted EBITDA Q4 $32.8M (+62% YoY); full year $119.7M (+103% YoY).","2025 guidance: revenue $1.40B-$1.44B, Center Margin $440M-$464M, Adj. EBITDA $130M-$150M.","Free cash flow $85.7M for 2024; cash $154.6M, net long-term debt $279.8M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-028099","json":"https://secwatch.observer/filing/0000950170-25-028099.json","markdown":"https://secwatch.observer/filing/0000950170-25-028099.md","text":"https://secwatch.observer/filing/0000950170-25-028099.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1845257/000095017025028099/0000950170-25-028099-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1845257/000095017025028099/lfst-20250227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T02:29:18.451468+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}